Health & BiotechBiotech ETFs Face Crucial FDA Week as Drug Catalysts Loom – State Street SPDR S&P Biotech ETF (ARCA:XBI) Tejash & Dev12 minutes ago01 mins XBI and IBB lagged SPY and QQQ as two FDA decisions and fresh Alzheimer’s and obesity-drug data put biotech ETFs in focus. Post navigation Previous: Nature and biodiversity – EnvironmentNext: Ohio State receives funding from Meta to advance medical research Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Yes, add me to your mailing list